Nearly 70% of patients with acute upper gastrointestinal (GI) bleeding and low-risk or no peptic ulcer disease received intravenous (IV) proton pump inhibitors (PPIs) inappropriately, leading to ...
ICU Medical, Inc. ICUI, yesterday, announced the FDA’s 510(k) clearance for the Plum Solo precision IV pump, a single-channel complement to the dual-channel Plum Duo. The company also received the 510 ...
Iradimed Corporation announced that it has received FDA 510(k) clearance for its next-generation MRidium® 3870 IV Infusion Pump System, making it the only supplier of non-magnetic MRI-compatible ...
Proton pump inhibitors (PPIs) are the most effective agents for treating acid related gastrointestinal (GI) disorders. The utilization of intravenous (IV) formulations of PPIs has dramatically ...
ICU Medical receives FDA clearance for Plum Duo infusion pump and LifeShield infusion safety software, part of the new ICU Medical IV performance platform ICU Medical Inc. wants hospitals to question ...
PITT COUNTY, N.C. (WITN) - Pitt County EMS fleets are now equipped with new IV infusion pump technology designed to provide safer medication and fluid delivery during emergencies. The advanced ...
Please provide your email address to receive an email when new articles are posted on . Zyno Medical is recalling select infusion pumps due to a software defect that may cause air bubbles to be passed ...
Hosted on MSN
IRADIMED targets $100M revenue milestone with new 3870 MRI IV pump rollout through 2026
Management raised Q4 2025 revenue guidance to $21.4 million to $22.4 million and GAAP diluted EPS guidance to $0.43 to $0.47, with non-GAAP diluted EPS of $0.47 to $0.50. For full year 2025, guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results